Research & Innovation

Image: From left to right - Drs. Stewart Gaede and Daniel Breadner November 29, 2023 The Baker Centre for Pancreatic Cancer at London Health Sciences Centre (LHSC) opened in 2019 as part of the vision of Rick and Shelley Baker . They generously

London Health Sciences Centre (LHSC) is a leading research-intensive acute care teaching hospital that attracts some of the brightest minds from around the world. As a system leader with a duty to support international best practices, research and

November 2, 2023 London Health Sciences Centre (LHSC) and St. Joseph’s Heath Care London (St. Joseph’s) are celebrating the installation of a Total Laboratory Automation (TLA) system within the clinical microbiology laboratory. The innovative and

Oct. 12, 2023 A recent study from London Health Sciences Centre and Lawson Health Research Institute suggests that using existing diagnostic CT scans in planning simple palliative radiation treatments can significantly cut down the waiting time for

September 15, 2023 Join Lawson Health Research Institute on Thursday, September 28th at Goodwill Industries for the return of Café Scientifique – “Uncovering Trauma: A Conversation about PTSD and Moral Injury.” This free event offers the opportunity

June 30, 2023 Recently published in The Journal of Translational Medicine , a team at Lawson Health Research Institute has discovered unique patterns of blood plasma proteins in patients with suspected long COVID that could act as a potential drug

June 14, 2023 For the first time in Canada, a robot-assisted deep brain stimulation surgery to treat seizures caused by epilepsy was successfully completed at the London Health Sciences Centre’s (LHSC) University Hospital (UH). Deep brain stimulation

June 13, 2023 In a national multicentre study, scientists at Lawson Health Research Institute and Western University are working to create rare isotopes that will be used as an important tool to help treat cancer. Currently, radiation therapy is a

March 10, 2023 A new study published in The Lancet Oncology suggests that a very precise, high-dose form of radiotherapy called stereotactic ablative radiotherapy (SABR) may be a new treatment option for patients with inoperable kidney cancer. Lawson